General Information of the Compound
Compound ID |
CP0417165
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(4S)-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-4-carboxy-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,5S,8S,14S)-8-(2-carboxyethyl)-2-(1H-imidazol-5-ylmethyl)-5-methyl-3,6,9,12,17-pentaoxo-1,4,7,10,13-pentazacycloheptadecane-14-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]butanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]hexanoyl]amino]-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C152H227N41O46
|
||||||||||||||||||
Molecular Weight |
3364.729
|
||||||||||||||||||
Canonical SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C152H227N41O46/c1-16-78(10)123(150(238)170-82(14)128(216)180-105(61-87-64-161-91-35-24-23-34-90(87)91)140(228)182-101(57-75(4)5)141(229)190-121(76(6)7)148(236)179-93(36-25-27-53-153)130(218)163-67-114(202)171-92(38-29-55-160-152(157)158)129(217)162-66-112(156)200)192-142(230)103(58-84-30-19-17-20-31-84)184-136(224)99(47-52-119(209)210)178-134(222)94(37-26-28-54-154)175-126(214)80(12)167-125(213)79(11)168-133(221)97(43-48-111(155)199)172-115(203)68-165-132(220)96(46-51-118(207)208)177-138(226)100(56-74(2)3)181-139(227)102(60-86-39-41-89(198)42-40-86)185-145(233)108(70-194)187-147(235)110(72-196)188-149(237)122(77(8)9)191-144(232)107(63-120(211)212)186-146(234)109(71-195)189-151(239)124(83(15)197)193-143(231)104(59-85-32-21-18-22-33-85)183-135(223)98-44-49-113(201)174-106(62-88-65-159-73-166-88)137(225)169-81(13)127(215)176-95(45-50-117(205)206)131(219)164-69-116(204)173-98/h17-24,30-35,39-42,64-65,73-83,92-110,121-124,161,194-198H,16,25-29,36-38,43-63,66-72,153-154H2,1-15H3,(H2,155,199)(H2,156,200)(H,159,166)(H,162,217)(H,163,218)(H,164,219)(H,165,220)(H,167,213)(H,168,221)(H,169,225)(H,170,238)(H,171,202)(H,172,203)(H,173,204)(H,174,201)(H,175,214)(H,176,215)(H,177,226)(H,178,222)(H,179,236)(H,180,216)(H,181,227)(H,182,228)(H,183,223)(H,184,224)(H,185,233)(H,186,234)(H,187,235)(H,188,237)(H,189,239)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,157,158,160)/t78-,79-,80-,81-,82-,83+,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,121-,122-,123-,124-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
OGKIYPYMXDSAIK-FSNAXOAFSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01356, Glucagon-like peptide 1 receptor